{"id":169895,"date":"2024-07-23T02:43:30","date_gmt":"2024-07-23T06:43:30","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/hookipa-pharma-announces-leadership-changes-to-intensify-focus-on-hb-200\/"},"modified":"2024-08-18T11:48:46","modified_gmt":"2024-08-18T15:48:46","slug":"hookipa-pharma-announces-leadership-changes-to-intensify-focus-on-hb-200","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hookipa-pharma-announces-leadership-changes-to-intensify-focus-on-hb-200.php","title":{"rendered":"HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200"},"content":{"rendered":"<p><![CDATA[NEW YORK and VIENNA, July  22, 2024  (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (\u201dHOOKIPA\u201d or the \u201cCompany\u201d), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Directors Dr. Malte Peters as Chief Executive Officer and Terry Coelho as Executive Vice President and Chief Financial Officer, effective July 22, 2024. They will both retain their positions on the Board of Directors (\u201cBoard\u201d).]]><\/p>\n<p>The rest is here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/07\/22\/2916520\/0\/en\/HOOKIPA-Pharma-Announces-Leadership-Changes-to-Intensify-Focus-on-HB-200.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200\">HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The rest is here: HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/hookipa-pharma-announces-leadership-changes-to-intensify-focus-on-hb-200.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-169895","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169895"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=169895"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169895\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=169895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=169895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=169895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}